Shares of ADC Therapeutics SA (NYSE:ADCT – Get Rating) have earned an average rating of “Moderate Buy” from the six ratings firms that are presently covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and four have assigned a buy rating to […]
ADC Therapeutics SA (NYSE:ADCT – Get Rating) saw a large increase in short interest during the month of April. As of April 15th, there was short interest totalling 7,320,000 shares, an increase of 5.5% from the March 31st total of 6,940,000 shares. Based on an average daily trading volume, of 573,600 shares, the short-interest ratio […]
Bank of America downgraded shares of ADC Therapeutics (NYSE:ADCT – Get Rating) from a neutral rating to an underperform rating in a research note issued to investors on Monday, The Fly reports. Other research analysts have also issued reports about the company. Royal Bank of Canada dropped their price objective on ADC Therapeutics from $18.00 […]
Bank of America lowered shares of ADC Therapeutics (NYSE:ADCT – Get Rating) from a neutral rating to an underperform rating in a report released on Monday, The Fly reports. ADCT has been the topic of several other research reports. Royal Bank of Canada lowered their target price on shares of ADC Therapeutics from $18.00 to […]
ADC Therapeutics SA (NYSE:ADCT – Get Rating) has been given an average rating of “Moderate Buy” by the six analysts that are covering the stock, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 1-year price target among […]